首页> 外文期刊>Journal of drug targeting >Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance
【24h】

Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance

机译:固体脂质纳米粒对多药耐药性的10-羟基喜树碱的细胞内靶传递

获取原文
获取原文并翻译 | 示例
           

摘要

The main objective of this study was to design a suitable drug delivery system for 10-hydroxycamptothecin (HCPT). In this study, HCPT-loaded solid lipid nanoparticle (HCPT-loaded SLN) was successfully prepared. The HCPT-loaded SLN was characterized by size, entrapment efficiency and drug release manner. The cytotoxicity of HCPT-loaded SLN was assessed in vitro using HepG2/HCPT cells and in vivo utilizing human tumor xenograft nude mouse model. HCPT-loaded SLN indicated the ability to target HepG2/HCPT cells and accumulated higher drug content in HepG2/HCPT cells. HCPT-loaded SLN enhanced the cytotoxicity of HCPT in a concentration-dependent manner. Based on these results, HCPT-loaded SLN suggested being a promising vehicle for liver-targeted drug delivery. Moreover, it can be of clinical interest to overcome multidrug resistance (MDR) effectively.
机译:这项研究的主要目的是为10-羟基喜树碱(HCPT)设计合适的药物递送系统。在这项研究中,成功​​制备了HCPT负载的固体脂质纳米颗粒(HCPT负载的SLN)。负载HCPT的SLN的特征在于尺寸,包封率和药物释放方式。使用HepG2 / HCPT细胞在体外评估加载HCPT的SLN的细胞毒性,并使用人肿瘤异种移植裸鼠模型在体内评估HCPT加载的SLN的细胞毒性。加载HCPT的SLN表示有能力靶向HepG2 / HCPT细胞,并在HepG2 / HCPT细胞中积累了更高的药物含量。加载HCPT的SLN以浓度依赖性方式增强了HCPT的细胞毒性。根据这些结果,装载HCPT的SLN有望成为有针对性的肝靶向药物输送工具。此外,有效克服多药耐药性(MDR)可能具有临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号